adalimumab
- Technology
Alvotech Disputes AbbVie’s Recent Allegations
Reykjavik, Iceland: Alvotech strongly disputes AbbVie’s allegations of wrongdoing relating to AVT02, Alvotech’s proposed biosimilar to HUMIRA® (adalimumab). Alvotech will…
Read More »